The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line
Open accessAbstract
Modified vaccinia virus Ankara (MVA), attenuated by over 500 passages in primary chick embryo fibroblasts (CEF), is presently being used as a safe expression vector. We compared the host ranges of MVA and the parental Ankara strain in CEF and 15 permanent cell lines. The cells could be grouped into three categories: permissive, semipermissive, and nonpermissive. For MVA, the permissive category consisted of primary CEF, a quail cell line derived from QT6, and the Syrian hamster cell line BHK-21. Only in BHK-21 cells did the virus yield approach that occurring in primary CEF. The semipermissive category included two African green monkey cell lines: BS-C-1 and CV-1. The nonpermissive category for MVA consisted of three human cell lines HeLa, 293, and SW 839; one rhesus monkey cell line FRhK-4; two Chinese hamster cell lines CHO and CHL; one pig cell line PK(15); and three rabbit cell lines RK13, RAB-9, and SIRC. The grouping for MVA with a restored K1L host range gene was similar except for the inclusion of RK13 cells among permissive lines. The grouping for the Ankara strain, however, was quite different with more permissive and semipermissive cell lines. Nevertheless, in cells that were permissive for MVA, the virus replicated to higher levels than Ankara, consistent with both positive and negative growth elements associated with the adaptation of MVA. The cell lines were also characterized according to their susceptibility to MVA-induced cytopathic effects, expression of a late promoter regulated reporter gene by an MVA recombinant, and stage at which virion morphogenesis was blocked. Finally, the permissive BHK-21 cell line was shown to be competent for constructing and propagating recombinant MVA, providing an alternative to primary CEF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,205
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter, G., & Moss, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10847 · Cited by 600
Self-citationChang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
Meyer, H., Sutter, G., & Mayr, A. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-5-1031 · Cited by 474
Blasco, R., & Moss, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5910-5920.1991 · Cited by 317
Self-citationPreparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0512s13 · Cited by 282
Self-citationNon‐replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
Sutter, G., Ohlmann, M., & Erfle, V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00843-x · Cited by 226
Rifampicin : a Specific Inhibitor of Vaccinia Virus Assembly
MOSS, B., ROSENBLUM, E. N., KATZ, E., & GRIMLEY, P. M. (1969) · Nature · doi:10.1038/2241280a0 · Cited by 201
Self-citationAINSWORTH, S. K., & KARNOVSKY, M. J. (1972) · Journal of Histochemistry & Cytochemistry · doi:10.1177/20.3.225 · Cited by 199
Vaccinia virus host range genes
Perkus, M. E., Goebel, S. J., Davis, S. W., Johnson, G. P., Limbach, K., Norton, E. K., & Paoletti, E. (1990) · Virology · doi:10.1016/0042-6822(90)90296-4 · Cited by 180
Duncan, S. A., & Smith, G. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1610-1621.1992 · Cited by 146
Rodrígúez, J. F., & Smith, G. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.18.5347 · Cited by 126
Wolffe, E. J., Moore, D. M., Peters, P. J., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2797-2808.1996 · Cited by 122
Wolffe, E. J., Katz, E., Weisberg, A. S., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3904-3915.1997 · Cited by 110
Host-range restriction of vaccinia virus E3L-specific deletion mutants
Beattie, E., Kauffman, E. B., Martínez, H. B., Perkus, M. E., Jacobs, B. L., Paoletti, E., & Tartaglia, J. (1996) · Virus Genes · doi:10.1007/bf00370005 · Cited by 102
Bender, B. S., Rowe, C. A., Taylor, S. F., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6418-6424.1996 · Cited by 94
Mapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene
Gillard, S., Spehner, D., & Drillien, R. (1985) · Journal of Virology · doi:10.1128/jvi.53.1.316-318.1985 · Cited by 45
Scheiflinger, F., Falkner, F. G., & Dorner, F. (1996) · Archives of Virology · doi:10.1007/bf01718324 · Cited by 25
Vaccinia (Smallpox) Vaccine Recommendations of the Immunization Practices Advisory Committee (ACIP)
(1991) · PsycEXTRA Dataset · doi:10.1037/e546372006-001 · Cited by 24
Cited by
McFadden, G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1099 · Cited by 523
Antoine, G., Scheiflinger, F., Dorner, F., & Falkner, F. G. (1998) · Virology · doi:10.1006/viro.1998.9123 · Cited by 507
Precopio, M. L., Betts, M. R., Parrino, J., Price, D. A., Gostick, E., Ambrozak, D. R., Asher, T. E., Douek, D. C., Harari, A., Pantaleo, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062363 · Cited by 488
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
Earl, P. L., Americo, J. L., Wyatt, L. S., Eller, L. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., Hartmann, C. J., Jackson, D. L., Kulesh, D. A., et al. (2004) · Nature · doi:10.1038/nature02331 · Cited by 455
Self-citationBisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Self-citation
Metadata
- Authors
- Carroll, M. W., & Moss, B.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 238
- Issue
- 2
- Pages
- 198-211
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1985767121
- Cited by
- 331
- References
- 19
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.